drugset / Trial / NCT03334838

Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients - Dietary Habits Study

NCT03334838

Phase 1 Completed 36 enrolled Bayer
RandomizedCrossoverOpen-labelTreatment

Summary

This study evaluated the effect of food on the absorption of the drug as well as safety and tolerability in adults suffering from chronic Chagas' disease In addition pharmacokinetics of the drug following 120 and 240 mg single doses will be assessed

Timeline

Start
2019-06-10
Primary completion
2019-11-07
Completion
2020-01-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Nifurtimox Small molecule 120 mg Oral
Subject Nifurtimox Small molecule 240 mg Oral

Indications